Trevi Therapeutics Inc (TRVI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.95B
Last updated: Nov 17, 2026 at 11:06 AM ET
Trevi Therapeutics Inc (TRVI) Competitors
The companies most similar to Trevi Therapeutics are Vera Therapeutics (VERA), Biohaven (BHVN) and Travere Therapeutics (TVTX). By market cap, Trevi Therapeutics ranks 7th of the 13 companies on this page; Travere Therapeutics (TVTX) is the largest at $4.86B. The median P/E of the 4 companies with a P/E is 16.2x.
Peer Comparison
TRVI's revenue growth of 0.0% is above the peer median of -0.7%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Trevi Therapeutics (TRVI) | $1.95B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Biohaven Ltd. (BHVN) | $2.09B | N/A | N/A | 0.0% | -315.9% | 0.0% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | $1.43B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Fortrea Holdings Inc. (FTRE) | $1.95B | 26.0x | 0.7x | -2.6% | 1.8% | -1.4% | 0.00% |
| Theravance Biopharma Inc (TBPH) | $884.18M | 95.1x | 8.4x | 51.6% | N/A | -20.9% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Nurix Therapeutics Inc (NRIX) | $1.69B | 6.4x | 2.3x | 42.0% | N/A | 8426.0% | 0.00% |
| Ocular Therapeutix Inc (OCUL) | $1.37B | N/A | 26.9x | 0.0% | -52.1% | -11.5% | 0.00% |
| Innoviva Inc (INVA) | $1.35B | 5.3x | 3.0x | 44.1% | 10.8% | -1.6% | 0.00% |
| Peer median | $1.83B | 16.2x | 7.8x | 0.0% | -35.7% | -0.7% | 0.00% |
Similar Companies
These are the 12 companies most similar to Trevi Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
| Biohaven Ltd. (BHVN) | Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders... | BHVN competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic... | GPCR competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Fortrea Holdings Inc. (FTRE) | Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. | FTRE competitors |
| Theravance Biopharma Inc (TBPH) | Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe... | |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Nurix Therapeutics Inc (NRIX) | Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development... | NRIX competitors |
| Ocular Therapeutix Inc (OCUL) | Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development... | OCUL competitors |
| Innoviva Inc (INVA) | Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California. | INVA competitors |
Frequently Asked Questions About TRVI
Who are Trevi Therapeutics' main competitors?
The companies most similar to Trevi Therapeutics include Vera Therapeutics (VERA), Biohaven (BHVN), Travere Therapeutics (TVTX), Structure Therapeutics Inc. American Depositary Shares (GPCR) and Vir Biotechnology (VIR), listed from the closest match.
Who is Trevi Therapeutics' biggest competitor?
Travere Therapeutics (TVTX) is the largest of the similar companies at $4.86B; Vera Therapeutics (VERA) is the closest match by business profile, size, sector and industry.
How does TRVI stock compare with its competitors?
TRVI's net margin is 0.0% against a peer median of 0.0%.
Which of Trevi Therapeutics' competitors pays a higher dividend?
Trevi Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Trevi Therapeutics bigger than its competitors?
No. Trevi Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Travere Therapeutics (TVTX) at $4.86B.
TRVI pages: Overview, Earnings, Forecast, Financials, Competitors